Is Randolph Specialty Group Practice Legit?

Randolph Specialty Group Practice exhibits a concerning financial trend, consistently operating at a deficit over the past decade. In the latest filing (202009), expenses of $23,734,386 significantly exceeded revenue of $20,702,907, resulting in a $3,031,479 shortfall. This pattern of spending more than it earns has led to a substantial accumulation of liabilities, which stood at $26,240,664 in 2020, far outweighing its assets of $3,673,247. This indicates a precarious financial position and raises questions about long-term sustainability. The organization's transparency regarding executive compensation is high, with 0% reported for officer compensation across all ten filings. However, the consistent operational losses and the growing debt burden are significant red flags for financial health. While the NTEE code E30 suggests a focus on specialty medical care, the financial data points to an organization struggling to manage its costs relative to its income, which could impact its ability to deliver on its mission effectively. Given the persistent deficits and the high liabilities-to-assets ratio, potential donors or stakeholders should exercise caution. A deeper dive into the specific nature of their expenses and revenue streams would be necessary to fully understand the underlying causes of these financial challenges and assess the organization's future viability.